Where Global Innovation
and Capital Meet
Sectors Art of CVCConsumerEnergyFinancialHealthIndustrialITMediaServicesStartupsTelecomsTransportUniversity

Page 181

Google delves into D2iQ acquisition options

The potential acquisition would reportedly value the HPE, Microsoft and Koch-backed cloud software provider below its most recent valuation but above $250m.

Apr 28, 2020

Oric ordains $120m initial public offering

Cancer therapy developer Oric, whose backers include Memorial Sloan, Taiho and Hartford HealthCare, floated at the top of its range in an expanded IPO.

Apr 27, 2020

Gojek goes for $130m Moka acquisition

SoftBank, Bank Mandiri and the corporate-backed EV Growth have exited digital payment technology provider Moka, which had raised $28m.

Apr 24, 2020

TapClicks takes AdStage in acquisition deal

Marketing analytics software provider Adstage had raised more than $15m from backers including Verizon, Digital Garage, HubSpot, Guidewire and Eloqua.

Apr 24, 2020

Chinese startups begin to fall from coronavirus

Wujiang Hotels, Baicheng and Meili Jinrong are among the first wave of China-based companies to close due to Covid-19 restrictions.

Apr 23, 2020

Digital.ai materialises through three-way merger

Following the January merger of XebiaLabs and CollabNet VersionOne, Purdue spinout Arxan Technologies has also joined the group, now dubbed Digital.ai.

Apr 22, 2020

Raycloud to beam itself to public markets

The Alibaba-backed e-commerce software and services provider is targeting $61.2m in an initial public offering on the Shanghai Stock Exchange.

Apr 22, 2020

Digital.ai materialises through three-way merger

Following the January merger of SIG-backed XebiaLabs and CollabNet VersionOne, Arxan Technologies has also joined the group, now dubbed Digital.ai.

Apr 22, 2020

Ruixin rushes to Shenzhen listing

BAIC has notched up an exit after the aluminium alloy component provider went public in a $47.8m offering on the Shenzhen Stock Exchange.

Apr 22, 2020

Asklepios pieces together BrainVectis acquisition

Huntington's disease therapy developer BrainVectis, a spinout of research institute Inserm, has been acquired having disclosed just $1m of equity funding in 2016.

Apr 22, 2020
© 2025 Mawsonia Ltd. All rights reserved.
test reg

Login

Not yet subscribed?

See your subscription offers here